Abstract:You have accessJournal of UrologyStone Disease: Basic Research & Pathophysiology I (MP03)1 Apr 2019MP03-11 GUT MICROBIOME AND SHORT CHAIN FATTY ACIDS IN RENAL CALCIUM OXALATE STONES FORMATION Kunjie Wang*, Yu Liu, Liang Zhou, Yi Li, Qun Sun, Zude Chen, Qingyao Jiang, Liang Cheng, Lei Tian, and Hong Li Kunjie Wang*Kunjie Wang* More articles by this author , Yu LiuYu Liu More articles by this author , Liang ZhouLiang Zhou More articles by this author , Yi LiYi Li More articles by this author , Qun SunQun Sun More articles by this author , Zude ChenZude Chen More articles by this author , Qingyao JiangQingyao Jiang More articles by this author , Liang ChengLiang Cheng More articles by this author , Lei TianLei Tian More articles by this author , and Hong LiHong Li More articles by this author View All Author Informationhttps://doi.org/10.1097/01.JU.0000554943.49324.a5AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVES: Calcium oxalate stone (60%-90%) is the most common type of nephrolithiasis, while the etiology is still unclear. Emerging evidence has linked the gut microbiome to nephrolithiasis. Some studies found that Oxalobacter formigenes, a member of the human gut microbiome, can degrade oxalate and obtain energy from it, which may decrease the level of oxalate in serum and urine. However, several prospective researches indicated that patients with calcium oxalate stones showed no significant change in urinary oxalate after oral administration of O. formigenes. Thus, the objectives of the study were to continually explore the gut microbiome and their metabolite which may play a major role in the formation of calcium oxalate stones. METHODS: We performed microbiome analysis using 16S ribosomal RNA (rRNA) amplicon sequencing on fecal samples from 160 Chinese individuals, including 23 with recurrent renal calcium oxalate stones (RS), 53 with single stones (SS) and 84 non-stones (NS) people. The α and β diversity analyses were performed with Mothur and QIIME, respectively. LefSe analysis was also employed to filter out significant gut bacteria between patients with nephrolithiasis and healthy people. Random forests analysis was used to find which Operational Taxonomic Units (OTUs) are of vital roles in predicting stone/non-stone status. Furthermore, we fed stone-forming Sprague - Dawley rats with or without acetic acid and examined the change of amount of crystal in kidney. RESULTS: We identified that RS (Chao1 index 3057.7±915.67 vs 2371.1±1233.6, p=0.015) and SS patients (Chao1 index 2899±1081.5 vs 2371.1±1233.6, p=0.012) both exhibited higher fecal microbial diversity than controls. We also found significant associations between total community composition and disease status by assessing β diversity. At phylum level, Firmicutes-Bacteroidetes ratio in RS group (3.595) was the highest, followed by OS (2.789) and NS group (2.646). At genus level, the abundance of Blautia, Lachnospiraceae, [Eubacterium] hallii and Faecalibacterium, all producing short chain fatty acids (SCFAs) (like acetic acid, propionic acid and butyric acid), were significantly lower in stone patients' gut microbiome, while Megamonasc, Lachnoclostridium, Acinetobacter, Halomonas, Empedobacter, Cellulosilyticum, Brevinema, Anaerosalibacter, Nocardia, Syntrophobacter were higher. By random forests analysis, we found 43 bacteria of great importance and then formed a predicting model based on them (area under curve = 0.76). In addition, the percentage of stone-forming rats who had kidney crystal decreased from 60% to 20% after oral administration of acetic acid. CONCLUSIONS: Our findings revealed association between gut microbiome alterations and renal calcium oxalate stones. SCFAs may prevent stone formation while the underlying mechanism is still unknown. It may be possible to prevent kidney stones by regulating gut microbiome composition and SCFAs production. We are likely to predict the formation of calcium oxalate stones by analyzing the composition of gut microbiome; however, further large-scale, multi-center researches are required to optimize the predicting model. Source of Funding: This study was supported by the National Natural Science Foundation of China (81770703, 81800667), Project of Science and Technology Department of Sichuan Province (2018SZ0118) and 1.3.5 Project for Disciplines of Excellence, West China Hospital, Sichuan University (ZY2016104). Chengdu, China, People's Republic of© 2019 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 201Issue Supplement 4April 2019Page: e24-e25 Advertisement Copyright & Permissions© 2019 by American Urological Association Education and Research, Inc.MetricsAuthor Information Kunjie Wang* More articles by this author Yu Liu More articles by this author Liang Zhou More articles by this author Yi Li More articles by this author Qun Sun More articles by this author Zude Chen More articles by this author Qingyao Jiang More articles by this author Liang Cheng More articles by this author Lei Tian More articles by this author Hong Li More articles by this author Expand All Advertisement PDF downloadLoading ...

Intestinal dysbacteriosis leads to kidney stone disease

Association of Dietary Patterns with Gut Microbiota in Kidney Stone and Non-Kidney Stone Individuals

The urinary microbiota composition and functionality of calcium oxalate stone formers

The Relationship Between Gut Microbiota and Short Chain Fatty Acids in the Renal Calcium Oxalate Stones Disease

MP03-11 GUT MICROBIOME AND SHORT CHAIN FATTY ACIDS IN RENAL CALCIUM OXALATE STONES FORMATION

Profiling the urinary microbiome in men with calcium-based kidney stones

The microbiome of calcium-based urinary stones

The Relationship between Urinary Stones and Gut Microbiomeby 16S Sequencing

The Status and Characteristics of Urinary Stone Composition in China

Impact of Intestinal Flora on Calcium Oxalate Stones.

Sex Disparities in the Association of Serum Uric Acid With Kidney Stone: A Cross-Sectional Study in China

The gut microbiota profile of adults with kidney disease and kidney stones: a systematic review of the literature

Gut microbiota in patients with kidney stones: a systematic review and meta-analysis

Differential oral and gut microbial structure related to systemic metabolism in kidney stone patients

Causal Relationship Between Kidney Stones and Gut Microbiota Contributes to the Gut-Kidney Axis: a Two-Sample Mendelian Randomization Study.

Characteristics of the urinary microbiome in kidney stone patients with hypertension

Metabolic Differences Between Unilateral and Bilateral Renal Stones and Their Association with Markers of Kidney Injury

Gut microbiota affect the formation of calcium oxalate renal calculi caused by high daily tea consumption

The pelvis urinary microbiome in patients with kidney stones and clinical associations

Unraveling Intestinal Microbial Shifts in ESRD and Kidney Transplantation: Implications for Disease-Related Dysbiosis

Impact of coexisting type 2 diabetes mellitus on the urinary microbiota of kidney stone patients